Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design of a spring-assisted exoskeleton module for wrist and hand rehabilitation.
Perry JC, Trimble S, Castilho Machado LG, Schroeder JS, Belloso A, Rodriguez-de-Pablo C, Keller T. Perry JC, et al. Among authors: schroeder js. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:594-597. doi: 10.1109/EMBC.2016.7590772. Annu Int Conf IEEE Eng Med Biol Soc. 2016. PMID: 28268400
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group. Abraham WT, et al. Among authors: schroeder js. Circulation. 2004 Nov 2;110(18):2864-8. doi: 10.1161/01.CIR.0000146336.92331.D1. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505095 Clinical Trial.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Young JB, et al. Among authors: schroeder js. JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685. JAMA. 2003. PMID: 12771115 Clinical Trial.
Infectious burden and atherosclerosis.
Schroeder JS. Schroeder JS. Curr Cardiol Rep. 2002 Jul;4(4):259. doi: 10.1007/s11886-002-0065-x. Curr Cardiol Rep. 2002. PMID: 12052264 No abstract available.
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial.
Theroux P, Chaitman BR, Erhardt L, Jessel A, Meinertz T, Nickel WU, Schroeder JS, Tognoni G, White H, Willerson JT. Theroux P, et al. Among authors: schroeder js. Curr Control Trials Cardiovasc Med. 2000;1(1):59-67. doi: 10.1186/cvm-1-1-059. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714411 Free PMC article.
Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.
Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT, Jessel A. Théroux P, et al. Among authors: schroeder js. Circulation. 2000 Dec 19;102(25):3032-8. doi: 10.1161/01.cir.102.25.3032. Circulation. 2000. PMID: 11120691 Clinical Trial.
199 results